|
RAB4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.555700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.384400E-01 |
| Normal-vs-Stage2 |
5.646800E-01 |
| Normal-vs-Stage3 |
2.348400E-01 |
| Normal-vs-Stage4 |
2.754800E-01 |
| Stage1-vs-Stage2 |
7.940000E-01 |
| Stage1-vs-Stage3 |
2.613200E-01 |
| Stage1-vs-Stage4 |
2.071600E-01 |
| Stage2-vs-Stage3 |
5.657400E-01 |
| Stage2-vs-Stage4 |
3.642200E-01 |
| Stage3-vs-Stage4 |
7.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.202590E-01 |
| Normal-vs-AfricanAmerican |
1.229650E-01 |
| Normal-vs-Asian |
7.415000E-01 |
| Caucasian-vs-AfricanAmerican |
7.070000E-01 |
| Caucasian-vs-Asian |
4.425800E-01 |
| AfricanAmerican-vs-Asian |
3.473200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.463800E-01 |
| Normal-vs-Female |
2.400500E-02 |
| Male-vs-Female |
1.637990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.082800E-01 |
| Normal-vs-Extreme_Weight |
8.188200E-01 |
| Normal-vs-Obese |
3.762100E-02 |
| Normal-vs-Extreme_Obese |
7.244400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.743600E-01 |
| Normal_Weight-vs-Obese |
3.430200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.869800E-01 |
| Extreme_Weight-vs-Obese |
9.304500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.486800E-01 |
| Obese-vs-Extreme_Obese |
6.090400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.075200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.696500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.803600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.383200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.089800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.439600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.728000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.166600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.056600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.823000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.266000E-01 |
| Normal-VS-Type2 PRCC |
3.749600E-01 |
| Normal-VS-KIRP CIMP |
1.178010E-01 |
| Normal-VS-Unclassified PRCC |
2.223400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.250600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.458190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.211200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.018010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.310400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.082000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.947400E-01 |
| Normal-vs-N1 |
2.980100E-02 |
| Normal-vs-N2 |
6.686000E-01 |
| N0-vs-N1 |
1.967870E-02 |
| N0-vs-N2 |
4.328400E-01 |
| N1-vs-N2 |
5.982400E-01 |
|
|
